Who
Joseph Echevarria
Director
Company insider
Files Form 4 as: Director, The Bank of New York Mellon; Director, Pfizer; Director, Unum Group; Director, Xerox Holdings; Director, Xerox.
In numbers
- Trades disclosed
- 167
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 1 Apr 2015
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | BNY The Bank of New York MellonRegional banks | SEC FORM 4 Code A | $90K625.347 at $143.92 | filing |
| 25 Sep 2026filed 29 Sep 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $46K1,613.185 at $28.67 | filing |
| 25 Sep 2026filed 29 Sep 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $46K1,613.19 at $28.67 | filing |
| 1 Jul 2026filed 6 Jul 2026 | BNY The Bank of New York MellonRegional banks | SEC FORM 4 Code A | $90K616.354 at $146.02 | filing |
| 1 Jul 2026filed 6 Jul 2026 | BNY The Bank of New York MellonRegional banks | SEC FORM 4 Code A | $90K616.35 at $146.02 | filing |
| 26 Jun 2026filed 30 Jun 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $46K1,904.076 at $24.29 | filing |
| 26 Jun 2026filed 30 Jun 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $46K1,904.08 at $24.29 | filing |
| 26 May 2026filed 28 May 2026 | UNM Unum GroupInsurance | SEC FORM 4 Code A | —2,191 at $0.00 | filing |
| 26 May 2026filed 28 May 2026 | UNM Unum GroupInsurance | SEC FORM 4 Code A | —1,540 at $0.00 | filing |
| 26 May 2026filed 28 May 2026 | UNM Unum GroupInsurance | SEC FORM 4 Code A | —2,191 at $0.00 | filing |
| 26 May 2026filed 28 May 2026 | UNM Unum GroupInsurance | SEC FORM 4 Code A | —1,540 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K7,686.539 at $26.67 | filing |
| 23 Apr 2026filed 27 Apr 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $205K7,686.54 at $26.67 | filing |
| 17 Apr 2026filed 21 Apr 2026 | Bank of New York Mellonoption or derivative · Regional banks | SEC FORM 4 Code A | —1,592 | filing |
| 17 Apr 2026filed 21 Apr 2026 | BNY The Bank of New York Mellonoption or derivative · Regional banks | SEC FORM 4 Code A | —1,592 | filing |
| 1 Apr 2026filed 3 Apr 2026 | Bank of New York MellonRegional banks | SEC FORM 4 Code A | $90K743.986 at $120.97 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BNY The Bank of New York MellonRegional banks | SEC FORM 4 Code A | $90K743.99 at $120.97 | filing |
| 27 Mar 2026filed 30 Mar 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $46K1,710.429 at $27.04 | filing |
| 27 Mar 2026filed 30 Mar 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $46K1,710.43 at $27.04 | filing |
| 2 Feb 2026filed 4 Feb 2026 | Bank of New York MellonRegional banks | SEC FORM 4 Code A | $84K688.364 at $121.61 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.